来自世界卫生组织。登革热和日本脑炎疫苗的研发。 - Suppr

Suppr

超能文献

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.

作者信息

Brandt W E

机构信息

Program for Vaccine Development, World Health Organization, Geneva, Switzerland.

出版信息

J Infect Dis. 1990 Sep;162(3):577-83. doi: 10.1093/infdis/162.3.577.

DOI:10.1093/infdis/162.3.577

PMID:1696952

Abstract

摘要

相似文献

From the World Health Organization. Development of dengue and Japanese encephalitis vaccines.来自世界卫生组织。登革热和日本脑炎疫苗的研发。

J Infect Dis. 1990 Sep;162(3):577-83. doi: 10.1093/infdis/162.3.577.

Vaccines aplenty.

Curr Opin Infect Dis. 2002 Oct;15(5):461-3. doi: 10.1097/00001432-200210000-00001.

Development of new vaccines against dengue fever and Japanese encephalitis.新型登革热和日本脑炎疫苗的研发。

Intervirology. 2001;44(2-3):176-97. doi: 10.1159/000050045.

Empirically derived live-attenuated vaccines against dengue and Japanese encephalitis.凭经验研制的登革热和日本脑炎减毒活疫苗。

Adv Virus Res. 2003;61:419-43. doi: 10.1016/s0065-3527(03)61011-0.

The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.四价登革热DNA疫苗对预先接触过日本脑炎或登革热病毒抗原的小鼠的免疫原性。

Asian Pac J Allergy Immunol. 2015 Sep;33(3):182-8. doi: 10.12932/AP0508.33.3.2015.

Dengue fever virus and Japanese encephalitis virus synthetic peptides, with motifs to fit HLA class I haplotypes prevalent in human populations in endemic regions, can be used for application to skin Langerhans cells to prime antiviral CD8+ cytotoxic T cells (CTLs)--a novel approach to the protection of humans.登革热病毒和日本脑炎病毒的合成肽，带有适合流行于疫区人群中的HLA I类单倍型的基序，可用于作用于皮肤朗格汉斯细胞以启动抗病毒CD8 +细胞毒性T细胞（CTL）——这是一种保护人类的新方法。

Virus Genes. 1994 Sep;9(1):33-45. doi: 10.1007/BF01703433.

Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting.

Vaccine. 1997 Oct;15(14):1494-502. doi: 10.1016/s0264-410x(97)00195-3.

From the World Health Organization. Current approaches to the development of dengue vaccines and related aspects of the molecular biology of flaviviruses.

J Infect Dis. 1988 May;157(5):1105-11. doi: 10.1093/infdis/157.5.1105.

The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus.嵌合型日本脑炎/登革2型病毒可保护小鼠免受登革病毒和日本脑炎病毒强毒株的攻击。

Protein Cell. 2017 Mar;8(3):225-229. doi: 10.1007/s13238-016-0363-5.

Japanese encephalitis vaccines.日本脑炎疫苗

Wkly Epidemiol Rec. 1998 Oct 30;73(44):337-44.

引用本文的文献

Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.四价重组登革病毒样颗粒作为潜在的疫苗候选物：免疫学特性

BMC Microbiol. 2014 Dec 18;14:233. doi: 10.1186/s12866-014-0233-3.

Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo.金合欢素在体外和体内抑制日本脑炎病毒感染。

Arch Virol. 2013 Feb;158(2):349-58. doi: 10.1007/s00705-012-1489-2. Epub 2012 Oct 7.

Incidence and seroprevalence of dengue virus infections in Australian travellers to Asia.澳大利亚亚洲旅行者登革热病毒感染的发病率和血清流行率。

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1203-10. doi: 10.1007/s10096-011-1429-1. Epub 2011 Oct 9.

Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain.登革热1型病毒西太平洋74株全长感染性克隆的构建。

Virus Genes. 2000;20(1):57-63. doi: 10.1023/a:1008160123754.

Attenuation markers of a candidate dengue type 2 vaccine virus, strain 16681 (PDK-53), are defined by mutations in the 5' noncoding region and nonstructural proteins 1 and 3.候选登革2型疫苗病毒16681株（PDK-53）的减毒标记由5'非编码区以及非结构蛋白1和3中的突变所定义。

J Virol. 2000 Apr;74(7):3011-9. doi: 10.1128/jvi.74.7.3011-3019.2000.

Dengue and dengue hemorrhagic fever.登革热和登革出血热。

Clin Microbiol Rev. 1998 Jul;11(3):480-96. doi: 10.1128/CMR.11.3.480.

Immunisation with DNA polynucleotides protects mice against lethal challenge with St. Louis encephalitis virus.用DNA多核苷酸免疫可保护小鼠免受圣路易斯脑炎病毒致死性攻击。

Arch Virol. 1996;141(3-4):743-9. doi: 10.1007/BF01718332.

Expression of cloned envelope protein genes from the flavivirus tick-borne encephalitis virus in mammalian cells and random mutagenesis by PCR.黄病毒蜱传脑炎病毒克隆包膜蛋白基因在哺乳动物细胞中的表达及通过聚合酶链反应进行随机诱变

Virus Genes. 1994 Jul;8(3):187-98. doi: 10.1007/BF01703077.

Protective efficacy in mice of a secreted form of recombinant dengue-2 virus envelope protein produced in baculovirus infected insect cells.

Arch Virol. 1994;139(1-2):197-207. doi: 10.1007/BF01309465.

Dengue virus protein recognition by virus-specific murine CD8+ cytotoxic T lymphocytes.病毒特异性小鼠CD8 + 细胞毒性T淋巴细胞对登革病毒蛋白的识别

J Virol. 1993 Feb;67(2):801-6. doi: 10.1128/JVI.67.2.801-806.1993.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验